Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

(2021) Dapeng Li et al.   CELL

Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks

(2021) Jacques Fantini et al.   JOURNAL OF INFECTION

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

(2020) Lihong Liu et al.   NATURE

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

(2020) Xiangyang Chi et al.   SCIENCE

Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19

(2020) Jacques Fantini et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains

(2009) H. Puerta-Guardo et al.   JOURNAL OF GENERAL VIROLOGY